Melanoma Focus Virtual Regional Meeting 2024
Friday 17th May 2024
Organised by: Dr Ricky Frazer, Consulant Oncologist, Velindre Cancer Centre, Cardiff
Location: Virtual
| Friday, 17th May 2024 | 9:00 am – 5:30 pm |
This meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s). The Royal College of Surgeons of England has awarded up to 6 CPD points. The British Association of Plastic, Reconstructive and Aesthetic Surgeons has awarded up to 6 CME credits.
If you are unsure about your membership, please email memberships@melanomafocus.org
If you have any questions about this event, please email jenn@melanomafocus.org
PROGRAMME
| 09:00-09:15 | Welcome/Introductions (Dr Mark Harries / Susanna Daniels/Dr Ricky Frazer) |
| 09:15-10:15 | Session 1: Melanoma for 2030 Chair: Dr Rebecca Lee, Senior Lecturer University of Manchester and Francis Crick/UCL; Consultant Medical Oncologist, The Christie NHS Foundation Trust |
| 09:15-09:45 | Melanoma for 2030: A horizon scan of future options and how do we get ourselves ready Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre and UCLH |
| 09:45-10:00 | Update on UK Skin Cancer Clinical Trials Group Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust |
| 10:00-10:15 | Q&A |
| 10:15-10:25 | Comfort Break |
| 10:25-11:25 | Session 2: A Novel Complex Melanoma MDT ‘Diagnosis, Staging and Response Assessment’ Chairs: Dr Aisling Butler, Consultant Radiologist, Velindre Cancer Centre & – Miss Sarah Hemington Gorse, Consultant Plastic Surgeon, Swansea Panel: – Dr Satish Kumar, Consultant Medical Oncologist, Velindre Cancer Centre – Michelle Norton CNS, Velindre Cancer Centre – Dr Jo Ocen, Consultant Medical Oncologist, Velindre Cancer Centre – Dr Allie Shipp, Consultant Medical Oncologist, Velindre Cancer Centre – Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre |
| 11:25-13:30 | Pharma Exhibition Area / Posters |
| 11:30-12:30 | PIERRE FABRE SPONSORED SYMPOSIUM Management of challenging BRAF mutant metastatic melanoma: a focus on the management of patients with brain metastases -Dr. Rebecca Lee -Dr. Chris Herbert |
| 13:30-15:05 | Session 3: Optimising Checkpoint Inhibitors in Melanoma Chair: Dr Anna Olsson-Brown, Consultant Medical Oncologist, Sussex Cancer Centre |
| 13:30-14:00 | The role of immunotherapy in patients with complex comorbidities Professor Jeff Weber, Interim Director, Laura and Isaac Perlmutter Cancer Center; Professor of Medicine and Perlmutter Professor of Oncology, NYU-Grossman School of Medicine |
| 14:00-14:25 | Cardiotoxicity and Baseline Testing -Dr Rebecca Dobson, Consultant Cardiologist, Liverpool Heart and Chest Hospital NHS Foundation Trust -Dr Clare Barlow, Consultant Medical Oncologist and Immunotherapy Lead, Somerset NHS Foundation Trust |
| 14:25-14:45 | Supporting professionals in the IO Space Dr Kate Young, Consultant Medical Oncologist, The Royal Marsden Hospital NHS Foundation Trust |
| 14:45-15:05 | Q&A |
| 15:05-15:10 | Comfort Break |
| 15:10-16:05 | Session 4: Supporting Patients in 2024 |
| 15:10-15:35 | What matters to patients in melanoma diagnosis and management? -Imogen Cheese, Founder of the Melanoma Patient Conference -Imogen Llewellyn, Stage 4 patient |
| 15:35-15:50 | Supporting the patient to support themselves – the PRIMM study Dr Veronique Bataille, Consultant Dermatologist, West Hertfordshire Teaching Hospitals NHS Trust and Kings College London |
| 15:50-16:05 | Q&A |
| 16:05-16:15 | Comfort Break |
| 16:15-17:25 | Session 5: MDT: Past Present and Future Chair: Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre Panel: – Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital NHS Foundation Trust – Professor Jeff Weber, Interim Director, Laura and Isaac Perlmutter Cancer Center; Professor of Medicine and Perlmutter Professor of Oncology, NYU-Grossman School of Medicine – Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System – Dr Chris Herbert, Consultant Clinical Oncologist, University Hospitals Bristol NHS Foundation Trust -Dr Anna Olsson-Brown, Consultant Medical Oncologist, Sussex Cancer Centre |
| 17:25-17:30 | Concluding Remarks and Close Dr Mark Harries, Chairman Melanoma Focus, Dr Ricky Frazer, Organiser |